Case Reports

Primary Localized Cutaneous Nodular Amyloidosis of the Thighs

Cutis. 2015 June;95(6):E24-E27

Primary localized cutaneous nodular amyloidosis (PLCNA) is a rare form of cutaneous amyloidosis. We report the case of a 65-year-old woman with multiple asymptomatic discrete nodules and atrophic plaques on the thighs of 4 years’ duration that had increased in number and size. Results of extensive clinical, histologic, and laboratory evaluation showed no evidence of systemic amyloidosis or myeloma. A diagnosis of PLCNA was made. The patient refused treatment due to the asymptomatic nature of the lesions, and follow-up examination 2.5 years later showed minimal progression of the disease.

PDF Download

Practice Points

The cutaneous lesions of primary localized cutaneous nodular amyloidosis (PLCNA) may present as single or multiple nodules, occasionally with overlying atrophic plaques and some with surface telangiectasia.
Primary localized cutaneous nodular amyloidosis may represent a localized plasma cell dyscrasia that can be associated with a monoclonal gammopathy or multiple myeloma.
Although PLCNA often is a benign cutaneous disorder, some patients can develop underlying systemic amyloidosis or even paraproteinemia.

References

1. Sakuma TH, Hans-Filho G, Arita K, et al. Familial primary localized cutaneous amyloidosis in Brazil. Arch Dermatol. 2009;145:695-699.

2. Rodermund OE. On amyloidosis cutis nodularis atrophicans (Gottron 1950). at the same time a contribution to the classification of amyloidosis [in German]. Arch Klin Exp Dermatol. 1967;230:153-171.

3. Chapel TA, Birmingham DJ, Malinowski YE. Nodular primary localized cutaneous amyloidosis. Arch Dermatol. 1977;113:1248-1249.

4. Criado PR, Silva CS, Vasconcellos C, et al. Extensive nodular cutaneous amyloidosis: an unusual presentation. J Eur Acad Dermatol Venereol. 2005;19:481-483.

5. Touart DM, Sau P. Cutaneous deposition diseases. part I [published correction appears in J Am Acad Dermatol. 1998;39:1042]. J Am Acad Dermatol. 1998;39(2, pt 1):149-171; quiz 172-174.

6. Borrowman TA, Lutz ME, Walsh JS. Cutaneous nodular amyloidosis masquerading as a foot callus. J Am Acad Dermatol. 2003;49:307-310.

7. Fujimoto N, Yajima M, Ohnishi Y, et al. Advanced glycation end product-modified beta2-microglobulin is a component of amyloid fibrils of primary localized cutaneous nodular amyloidosis. J Invest Dermatol. 2002;118:479-484.

8. Clement CG, Truong LD. An evaluation of Congo red fluorescence for the diagnosis of amyloidosis. Hum Pathol. 2014;45:1766-1772.

9. Lien MH, Railan D, Nelson BR. The efficacy of dermabrasion in the treatment of nodular amyloidosis. J Am Acad Dermatol. 1997;36(2, pt 2):315-316.

10. Taylor SC, Baker E, Grossman ME. Nodular vulvar amyloid as a presentation of systemic amyloidosis. J Am Acad Dermatol. 1991;24:139.

11. Northcutt AD, Vanover MJ. Nodular cutaneous amyloidosis involving the vulva. case report and literature review. Arch Dermatol. 1985;121:518-521.

12. Yoneyama K, Tochigi N, Oikawa A, et al. Primary localized cutaneous nodular amyloidosis in a patient with Sjögren’s syndrome: a review of the literature. J Dermatol. 2005;32:120-123.

13. Summers EM, Kendrick CG. Primary localized cutaneous nodular amyloidosis and CREST syndrome: a case report and review of the literature. Cutis. 2008;82:55-59.

14. Taniguchi Y, Horino T, Terada Y. Cutaneous amyloidosis associated with amyopathic dermatomyositis. J Rheumatol. 2009;36:1088-1089.

15. Woollons A, Black MM. Nodular localized primary cutaneous amyloidosis: a long-term follow-up study. Br J Dermatol. 2001;145:105-109.

16. Brownstein MH, Helwig EB. The cutaneous amyloidoses. I. localized forms. Arch Dermatol. 1970;102:8-19.

Case Report

Clinical Findings

A 65-year-old woman presented with multiple asymptomatic discrete nodules and atrophic plaques on the thighs of 4 years’ duration. The lesions had started as 2 small, asymptomatic, madder red plaques symmetrically located on the anterior aspect of each thigh that had gradually increased in number and size, particularly on the right thigh. Two years later, 2 new atrophic plaques appeared on the anterior aspect of each. The lesions developed slowly but never remitted and had been misdiagnosed as primary macular atrophy of skin by several outpatient clinics. The patient’s general health was good and her personal and family history was unremarkable.

Physical examination revealed multiple madder red plaques and nodules of various shapes and sizes (ie, 1–3 cm in diameter) on the anterior aspect of the right thigh. The lesions were slightly elevated with a waxy surface, firm, and painless to palpation. One similar lesion was noted on the anterior aspect of the left thigh. Two 2-cm, brown-red, atrophic plaques also were noted in a symmetrical distribution on the anterior aspect of each thigh. The plaque surfaces were slightly crinkly and shiny, and anetodermalike lesions produced a buttonhole sign identical to a neurofibroma on palpation (Figure 1).

^{Figure 1. Multiple madder red plaques, nodules, and atrophic plaques in various shapes and sizes were seen on the anterior aspect of both thighs.}

Histopathologic Findings

Two biopsy specimens were taken from a nodule and an atrophic plaque on the right thigh. Microscopic examination revealed deposition of homogeneous eosinophilic material in the reticular dermis and subcutis as well as around the fine vessels (Figure 2A). There was mild cellular infiltration of lymphocytes, plasma cells, and giant cells in the dermis, especially adjacent to deposits and around the vessels (Figure 2B). The homogeneous material appeared salmon pink on Congo red staining and bright green by thioflavin T staining using a fluorescent microscope (Figures 3 and 4). These results suggested the characteristic features of cutaneous nodular amyloidosis.

^{Figure 2. Histopathologically, homogeneous eosinophilic material deposited in the reticular dermis and subcutis was noted (A)(H&E, original magnification ×25). Microscopic examination showed lymphocytes and plasma cells infiltrated in the dermis, especially adjacent to deposits and around the vessels (B)(H&E, original magnification ×200).}

^{Figure 3. Congo red staining showed salmon pink homogeneous material (original magnification ×25).}

^{Figure 4. Thioflavin T staining showed bright green homogeneous material (original magnification ×100).}

Laboratory Findings

Laboratory studies showed normal results for complete blood cell count, urinalysis, liver and renal function tests, blood glucose levels, lipid panel, and erythrocyte sedimentation rate. Serum protein electrophoresis was normal and no Bence Jones proteins were detected. Serum IgA, IgG, and IgM levels showed no abnormalities. Electrocardiogram, chest radiography, and abdominal ultrasound were normal.

A diagnosis of primary localized cutaneous nodular amyloidosis (PLCNA) was made based on clinical, histopathologic, and laboratory findings. Although surgical excision in stages was proposed, the patient refused treatment because the lesions were asymptomatic. There was no obvious progression of the skin lesions and no abnormal systemic findings during 2.5 years’ follow-up.

Comment

Amyloidosis is a spectrum of diseases consisting of deposition of amyloid proteins in various tissues. Clinically, amyloidosis is divided into both primary and secondary forms of systemic amyloidosis, hemodialysis-associated amyloidosis, heredofamilial amyloidosis, and cutaneous amyloidosis. Primary cutaneous amyloidosis is localized to the skin without other organ involvement and does not occur in systemic amyloidosis. Secondary cutaneous involvement in systemic amyloidosis is rare. Most cases of primary localized cutaneous amyloidosis (PLCA) are sporadic but approximately 10% of cases may be familial.¹ There are 3 main forms of localized cutaneous amyloidosis: macular, lichen, and nodular amyloidosis. Nodular cutaneous amyloidosis is the rarest form of PLCA.

Nodular amyloidosis was first described by Gottron in 1950.² Its cutaneous lesions may present as single or multiple nodules, occasionally with overlying atrophic plaques. The lesions consist of firm, smooth-surfaced, waxy or rubbery, pink to tan papules, plaques, or nodules measuring up to several centimeters. On some lesions, surface telangiectasia may be seen. Bullous-appearing and anetodermalike lesions have been reported.³ The acral region is the most common location, followed by the legs, head, trunk, arms, and genitalia, respectively.⁴ In some cases the lesions can spontaneously improve over time. In our patient, the lesions were composed of both multiple nodules and atrophic plaques, which is uncommon.

The pathogenesis of amyloid deposition is still unknown. Cutaneous macular and lichen amyloidosis may originate from degenerated keratinocyte intermediate filaments. Nodular amyloidosis may represent a localized plasma cell dyscrasia that can be associated with a monoclonal gammopathy or multiple myeloma.⁵ Some components of amyloid in some cases of PLCNA may consist of κ and λ immunoglobulin light chains, with most reported cases being of the l subtype.⁶ The results of one study indicated that β₂-microglobulin was another major component of amyloid fibrils and that β₂-microglobulin was partly subjected to the modification of advanced glycation end product in PLCNA.⁷